BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9201689)

  • 1. Quantitative assessment of tuftsin receptor expression and second messenger during in vitro differentiation of peripheral blood derived monocytes of leprosy patients.
    Khare S; Bhutani LK; Rao DN
    Mol Cell Biochem; 1997 Jun; 171(1-2):1-10. PubMed ID: 9201689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of human lepromatous monocyte-macrophage functions in vitro by tuftsin.
    Iyer RR; Prasad HK; Bhutani LK; Rao DN
    Int J Immunopharmacol; 1990; 12(8):847-58. PubMed ID: 2292463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of reactive nitrogen intermediates from the peripheral blood-derived monocytes/macrophages of leprosy patients stimulated in vitro by tuftsin.
    Khare S; Bhutani LK; Rao DN
    Lepr Rev; 1997 Mar; 68(1):16-24. PubMed ID: 9121327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of peripheral blood derived monocytes/macrophages from leprosy patients using 'tuftsin' for production of reactive oxygen intermediates.
    Khare S; Bhutani LK; Rao DN
    Lepr Rev; 1993 Sep; 64(3):208-18. PubMed ID: 8231600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tuftsin stimulation on the microbicidal activity exerted by blood monocyte-macrophages of leprosy patients.
    Iyer RR; Prasad HK; Bhutani LK; Rao DN
    Int J Immunopharmacol; 1990; 12(8):859-69. PubMed ID: 2292464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuftsin].
    Mücke D
    Allerg Immunol (Leipz); 1984; 30(3):127-38. PubMed ID: 6209973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
    Kaur J; Khare S; Bhutani LK; Rao DN
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin.
    Stabinsky Y; Bar-Shavit Z; Fridkin M; Goldman R
    Mol Cell Biochem; 1980 Apr; 30(2):71-7. PubMed ID: 6247642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
    Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of the augmentation of the phagocytic capability of phagocytic cells by Tuftsin, substance P, neurotensin, and kentsin and the interrelationship between their receptors.
    Goldman R; Bar-Shavit Z
    Ann N Y Acad Sci; 1983; 419():143-55. PubMed ID: 6201115
    [No Abstract]   [Full Text] [Related]  

  • 12. Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms.
    Dagan S; Tzehoval E; Fridkin M; Feldman M
    J Biol Response Mod; 1987 Dec; 6(6):625-36. PubMed ID: 3502474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuftsin-macrophage interaction: specific binding and augmentation of phagocytosis.
    Bar-Shavit Z; Stabinsky Y; Fridkin M; Goldman R
    J Cell Physiol; 1979 Jul; 100(1):55-62. PubMed ID: 381320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.
    Sadhu S; Khaitan BK; Joshi B; Sengupta U; Nautiyal AK; Mitra DK
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004338. PubMed ID: 26751584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional tuftsin binding sites on macrophage-like tumor line P388D1 and on bone marrow cells differentiated in vitro into mononuclear phagocytes.
    Bar-Shavit Z; Bursuker I; Goldman R
    Mol Cell Biochem; 1980 May; 30(3):151-5. PubMed ID: 6893215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuftsin induces tissue factor-like activity in human mononuclear cells and in monocytic cell lines.
    Kornberg A; Catane R; Peller S; Kaufman S; Fridkin M
    Blood; 1990 Aug; 76(4):814-9. PubMed ID: 2383658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.
    Fridkin M; Gottlieb P
    Mol Cell Biochem; 1981 Dec; 41():73-97. PubMed ID: 7035869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM; Mineo JR; Foss NT
    Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulation of oxygen metabolism in human blood phagocytes as affected by tuftsin-like peptides derived from the C-reactive protein molecule].
    Polevshchikov AV; Nazarov PG
    Biull Eksp Biol Med; 1993 Jan; 115(1):55-6. PubMed ID: 8054580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of dendritic cells in the cutaneous lesions associated with tuberculoid and lepromatous leprosy.
    Collings LA; Waters MF; Poulter LW
    Clin Exp Immunol; 1985 Dec; 62(3):458-67. PubMed ID: 3910315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.